📌 Key Takeaways
- Topic: 600 Mesh Silica: Particle Size, Specifications and Common Applications
- Keywords: silica supplier China
- Published: 2026-11-20 05:41:47
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Highly Dispersible Silica (HDS)? Benefits for Tire Performance Explained
- Silica for Rheology Control: How to Select the Right Silica and Dosage
- Sha, Z. et al. Manganese-doped gold core mesoporous silica particles as a nanoplatform for dual-modality imaging and chemo-chemodynamic combination osteosarcoma therapy. Nanoscale 13, 5077-5093 (2021). Article CAS PubMed Google Scholar
- What Is Nano Silica? Particle Size, Properties, Production and Applications
- Targeted delivery tactics are generally divided into two categories: passive targeting and active targeting. Passive targeting relies on the pathological qualities of the disease microenvironment and the nature of the drug delivery system itself, which allows the drug to effectively accumulate at the lesion site of disease. The most well-known passive targeting is the EPR effect of tumor, which refers to the phenomenon that some particles with particular size (20-200 nm) penetrate more without difficulty into tumor tissue and remain there for a long time when compared to normal tissue. 316, 317 Therefore, controlling the size of MSNs to a fitting range will facilitate their enrichment in the tumor sites. However, it has also been highlighted that the passive targeting strategy relying on the EPR effect can attain only 0.7% of the injected NPs enrichment in solid tumors, 318 which will not be handy for the clinical translation of nanotechnology. In contrast, active targeting relies on the active recognition between the molecules on the NPs surface and the specific molecules or proteins in the illness microenvironment, which is also referred to as ligand-receptor specific binding. 319 The active targeting shows a higher drug delivery efficiency compared to passive targeting. 320 Targeted ligands, such as proteins, antibodies, peptides, nucleic acids and chemical tiny molecules, can be modified on the surface of MSNs, and the modified MSNs are capable of selectively aggregating at the lesion site based on the powerful affinity between the targeted ligands and the particular receptors overexpressed in the sickness microenvironment. 321, 322, 323, 324 For instance, compared to mature vascular endothelial cells, tumor neovascular endothelial cells are highly expressed in an array of proteins, such as integrins, transmembrane glycoproteins and aminopeptidase N. Molecules that recognize these highly expressed proteins can be used for neovascular-based targeted drug delivery. A standard example is that arginylglycylaspartic acid (RGD)-modified MSNs can selectively bind integrin α ν β 3 receptor and hence be applied to target tumor neovascularization. 325
- What Is Silica Gel? How It Works, Types and Uses as a Desiccant and Adsorbent
- Yue, J. et al. Light-triggered multifunctional nanoplatform for productive cancer photo-immunotherapy. J. Nanobiotechnol. 20, 1-16 (2022). Article Google Scholar
- Silica for 3D Printing: Uses in Resins, Powders and Binder Jetting
- Liu, X. & Che, S. Boosted release of the poorly soluble drug itraconazole loaded in ordered mesoporous silica. Sci. China Chem. 58, 400-410 (2015). Article CAS Google Scholar
Silica for Floor Coatings: Anti-Slip, Matting and Rheology Functions
What is silica (SiO₂)?
fused silica
What is the difference between fumed silica and precipitated silica?
Aerosil alternative
What drives silica raw material prices?
silica gel column chromatography MSNs are gradually being developed as promising drug delivery carriers due to their brilliant biocompatibility, biodegradability, and greatly ordered pore structure. Owing to the great flexibility in tuning the surface properties of MSNs, specific surface functionalization modification of MSNs can achieve precise modulation of drug delivery behavior, thus to meet the application requirements. Currently, the most researched is the construction of stimuli-responsive MSNs-based drug delivery system (Fig. 6c ), i.e., when MSNs reach the lesion site, the release of drugs is controllably stimulated by specific internal or external components, thus achieving the improved drug utilization and staying away from drug leakage at non-lesion sites. 259, 272, 331 The most core step in this process is connecting some caps with stimulus-responsive properties onto the MSNs surface, which can be called gatekeepers, 119, 158 nanovalves, 332, 333 or others. Once the therapeutic drug is filled into the mesopore of MSNs, the pore entrances are blocked by the caps to prevent the drug from diffusing out. Under normal physiological conditions, the caps always keep the pores in a closed state, but when reaching to the lesion, the caps are separated under the stimulation of certain components, which in turn induces targeted on-demand release of drugs. These caps can be polymers, 334 metal/metal compound NPs, 170, 335 biomolecules, 336 etc. While exogenous stimuli such as light, ultrasound, magnetic field and electric field, endogenous stimuli such as temperature, pH, redox agents, and enzymes, can activate the caps. Several examples about the surface modification of MSNs and the corresponding stimuli-responsive plans are briefly clarified here.
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.